Literature DB >> 17504169

Artificial intelligence approaches for rational drug design and discovery.

Włodzisław Duch1, Karthikeyan Swaminathan, Jarosław Meller.   

Abstract

Pattern recognition, machine learning and artificial intelligence approaches play an increasingly important role in rational drug design, screening and identification of candidate molecules and studies on quantitative structure-activity relationships (QSAR). In this review, we present an overview of basic concepts and methodology in the fields of machine learning and artificial intelligence (AI). An emphasis is put on methods that enable an intuitive interpretation of the results and facilitate gaining an insight into the structure of the problem at hand. We also discuss representative applications of AI methods to docking, screening and QSAR studies. The growing trend to integrate computational and experimental efforts in that regard and some future developments are discussed. In addition, we comment on a broader role of machine learning and artificial intelligence approaches in biomedical research.

Mesh:

Year:  2007        PMID: 17504169     DOI: 10.2174/138161207780765954

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  17 in total

Review 1.  Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling.

Authors:  Linlin Zhao; Heather L Ciallella; Lauren M Aleksunes; Hao Zhu
Journal:  Drug Discov Today       Date:  2020-07-11       Impact factor: 7.851

2.  Composite multi-parameter ranking of real and virtual compounds for design of MC4R agonists: renaissance of the Free-Wilson methodology.

Authors:  Ingemar Nilsson; Magnus O Polla
Journal:  J Comput Aided Mol Des       Date:  2012-10-02       Impact factor: 3.686

Review 3.  Big Data and Artificial Intelligence Modeling for Drug Discovery.

Authors:  Hao Zhu
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-13       Impact factor: 13.820

4.  Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice.

Authors:  Miriam Redondo; Valle Palomo; José Brea; Daniel I Pérez; Rocío Martín-Álvarez; Concepción Pérez; Nuria Paúl-Fernández; Santiago Conde; María Isabel Cadavid; María Isabel Loza; Guadalupe Mengod; Ana Martínez; Carmen Gil; Nuria E Campillo
Journal:  ACS Chem Neurosci       Date:  2012-08-08       Impact factor: 4.418

5.  QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.

Authors:  Fang Zheng; Matthew J McConnell; Chang-Guo Zhan; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem       Date:  2009-05-08       Impact factor: 3.641

6.  Molecular Docking: From Lock and Key to Combination Lock.

Authors:  Ashutosh Tripathi; Vytas A Bankaitis
Journal:  J Mol Med Clin Appl       Date:  2017-02-10

7.  Molecular docking studies of gyrase inhibitors: weighing earlier screening bedrock.

Authors:  H S Santosh Kumar; S Ravi Kumar; N Naveen Kumar; S Ajith
Journal:  In Silico Pharmacol       Date:  2021-01-01

Review 8.  Survey of public domain software for docking simulations and virtual screening.

Authors:  Jacek Biesiada; Aleksey Porollo; Prakash Velayutham; Michal Kouril; Jaroslaw Meller
Journal:  Hum Genomics       Date:  2011-07       Impact factor: 4.639

Review 9.  Artificial intelligence to deep learning: machine intelligence approach for drug discovery.

Authors:  Rohan Gupta; Devesh Srivastava; Mehar Sahu; Swati Tiwari; Rashmi K Ambasta; Pravir Kumar
Journal:  Mol Divers       Date:  2021-04-12       Impact factor: 3.364

Review 10.  An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.

Authors:  Arun Bahadur Gurung; Mohammad Ajmal Ali; Joongku Lee; Mohammad Abul Farah; Khalid Mashay Al-Anazi
Journal:  Biomed Res Int       Date:  2021-06-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.